产前糖皮质激素时机对极低出生体重儿脑损伤的影响
这项历史性队列研究纳入189例极低出生体重儿,其中73.5%接受了完整产前糖皮质激素疗程。暴露于完整疗程的婴儿白质病变和 moderate/severe IVH 发生率更低;在<28周极早产儿中,出生前7天内给药者IVH显著更少。2岁时脑生长、成熟及神经发育无显著差异。
要点
- 完整产前糖皮质激素疗程与极低出生体重儿脑损伤率降低相关。
- 极早产儿出生前7天内给药,IVH发生显著减少。
- 2岁时脑生长、成熟及神经发育未见不良影响。
核心结论
- 完整产前糖皮质激素疗程与极低出生体重儿未调整的脑损伤率降低相关。
- 在极早产儿中,出生前7天内给药时IVH显著更少,且对2岁脑生长、成熟及神经发育无不良影响。
研究设计与样本
- 收集产前糖皮质激素给药时机等临床数据,比较有无完整疗程及不同给药至出生间隔的结局。
主要发现
- 139例(73.5%)接受完整产前糖皮质激素疗程。
- 暴露于完整疗程的婴儿白质病变发生率更低(p=0.02),moderate/severe IVH发生率更低(p=0.04)。
- 在<28周极早产儿中,出生前7天内给药者IVH显著更少(p=0.006)。
- 2岁时脑生长、成熟及神经发育结局无显著差异。
临床怎么用
- 对于预期极早产者,应关注产前糖皮质激素给药至出生的间隔,7天内给药可能对减少IVH更有益。
- 完整产前糖皮质激素疗程可用于降低极低出生体重儿脑损伤风险,无需担心对2岁神经发育的不良影响。
局限性
- 本研究为历史性队列研究,结论基于未调整分析。
- 单中心研究,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Timing matters: antenatal corticosteroids reduce brain injury in very low birth weight infants, but their protective effect in extremely preterm neonates declines when birth occurs beyond 7 days from administration. Abstract Introduction Antenatal corticosteroids (ACS) are widely used to improve outcomes in preterm infants, with known benefits on respiratory morbidity and intraventricular hemorrhage (IVH). However, the effect of ACS timing on brain injury and development remains unclear. We aimed to evaluate the impact of a complete course of ACS (ccACS), with particular attention to timing, on brain lesions, growth, and neurodevelopment in very low birth weight (VLBW) infants using magnetic resonance imaging (MRI). Material and Methods In this historical cohort study, all VLBW infants admitted to a tertiary neonatal intensive care unit between January 2019 and December 2021 were included. Clinical data, including timing of ACS administration, were collected. The primary outcome was the occurrence of brain injury on MRI at term-equivalent age, including IVH, white matter lesions (WML), and cerebellar hemorrhage (CBH). Secondary outcomes were brain growth and maturation on MRI and neurodevelopment at 2 years assessed using the Griffiths Mental Development Scales. Outcomes were compared between infants with and without ccACS and according to different administration-to-birth intervals. Results A total of 189 infants were included, of whom 139 (73.5%) received ccACS. Infants exposed to ccACS had a lower incidence of WML (p = 0.02) and moderate/severe IVH (p = 0.04). In extremely preterm infants (<28 weeks), IVH was significantly less frequent when ccACS was administered within 7 days before birth (p = 0.006). No significant differences were observed in brain growth, maturation, or neurodevelopmental outcomes at 2 years. Conclusions A complete course of ACS was associated with unadjusted lower rates of brain injury in VLBW infants, particularly when administered within 7 days before birth in extremely preterm infants, without adverse effects on brain growth, maturation, or neurodevelopment at 2 years.
引用
- Acta Obstetricia et Gynecologica Scandinavica:MRI BRAIN lesions and growth after antenatal steroids in preterm infants: Does timing matter?
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。